ORKA Sale Disclosure
Goncalves Joana · SEC Form 4 · Filed Sep 15, 2026
Sale
Calculated transaction value
$289.89K
Goncalves Joana Chief Medical Officer
ORKA
Oruka Therapeutics
ORKA
Transaction date
Sep 15, 2026
Public filing date
Sep 15, 2026
Filing lag
Filed same day
ORKA daily price context
Close on/before transaction
$92.2
Sep 15, 2026
Close before public filing
$95.93
Sep 14, 2026
Return since public filing
-2.48%
Through Sep 16, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 3,150 shares @ $92.03
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0000907654-26-000098
Filing cohort
Transactions in this filing
Showing 9 of 9
Trades
9
Issuers
1
Estimated value
$785.38K
Buys / sales
0 / 5
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Oruka Therapeutics, Inc. ORKA | Sale | Sep 15, 2026 | $90.64K |
| Oruka Therapeutics, Inc. ORKA | Sale | Sep 15, 2026 | $9.42K |
| Oruka Therapeutics, Inc. ORKA | Exercise | Sep 15, 2026 | $0 |
| Oruka Therapeutics, Inc. ORKA | Exercise | Sep 15, 2026 | $23.94K |
| Oruka Therapeutics, Inc. ORKA Current | Sale | Sep 15, 2026 | $289.89K |
| Oruka Therapeutics, Inc. ORKA | Exercise | Sep 15, 2026 | $27.3K |
| Oruka Therapeutics, Inc. ORKA | Sale | Sep 15, 2026 | $217.17K |
| Oruka Therapeutics, Inc. ORKA | Sale | Sep 15, 2026 | $127.02K |
| Oruka Therapeutics, Inc. ORKA | Exercise | Sep 15, 2026 | $0 |